Posters
Visual outcomes of patients implanted with a Clareon® intraocular lens
Poster Details
First Author: M.García-Domene SPAIN
Co Author(s): M. Penadés Fons E. Fernández López M. Roig Revert C. Peris Martínez
Abstract Details
Purpose:
To assess visual acuity and corneal changes one month after surgery
Setting:
FISABIO-Oftalmología Médica (FOM). Valencia, Spain.
Methods:
This is a retrospective study. The inclusion criteria were patients implanted with a Clareon® IOL in our center during year 2018 (Alcon Laboratories, Inc., Fort Worth, Texas.USA), preoperative corneal astigmatism less than 1.5D and without complications during the cataract surgery.
Exclusion criteria were patients with ocular or systemic pathologies like diabetes or hypertension, who had undergone any ocular surgery or taken drugs that may distort the results.
We have extracted data of corneal astigmatism pre-surgery and data of corneal astigmatism, subjective refraction and best corrected visual acuity (BCVA) one month after surgery.
Results:
We included 100 eyes from 100 patients. Mean age was 70±9 years. Corneal astigmatism pre-surgery was 0.7±0.3D. Corneal changes obtained from M, J0 and J45, were: sphere 0.2±0.3D and astigmatism -0.4±0.3D. If we compare data pre and post-surgery with a paired T-Test, the corneal changes aren’t statistically significant (p=0.85, p=0.19, p=0.86). One month after surgery, corneal astigmatism was 0.7±0.4D. Subjective refraction was: sphere 0.3±0.7D and astigmatism 0.7±0.6D. More than 90% of subjects had a spherical equivalent of 0.75D or less. The decimal BCVA was 0.9 or more for 90% of patients.
Conclusions:
100 cataract operated patients implanted with a Clareon® IOL have been included in this study. The corneal changes one month after surgery are not statistically significant. The visual results with this IOL were satisfactory since more than 74% of patients have a very good visual acuity and the subject refraction was quite low for more than 90% of patients.
Financial Disclosure:
None
